Brief: Ligand To Acquire Apeiron Biologics AG For $100 Million

Ligand Pharmaceuticals Incorporated

08/07/2024 13:11

July 8 (Reuters) - Ligand Pharmaceuticals Inc  LGND.O :
    * LIGAND TO ACQUIRE APEIRON BIOLOGICS AG FOR $100 MILLION
    * LIGAND PHARMACEUTICALS INC - LIGAND INCREASES 2024
ADJUSTED EPS
GUIDANCE RANGE BY 17% TO $5.00-$5.50
    * LIGAND PHARMACEUTICALS- DEAL TO BE IMMEDIATELY ACCRETIVE
TO
LIGAND EPS BY ESTIMATED $1.00 PER SHARE ON AN ANNUALIZED BASIS
WITH A $0.50 IMPACT TO 2024
    * LIGAND PHARMACEUTICALS INC - ACQUISITION PROVIDES LIGAND
WITH
ROYALTY RIGHTS TO QARZIBA®
    * LIGAND PHARMACEUTICALS INC: INCREASING 2024 REVENUE
GUIDANCE TO
BE IN RANGE OF $140 MILLION TO $157 MILLION

Source text for Eikon:  ID:nBw1d5GTXa 
Further company coverage:  LGND.O 

 ((Reuters.Briefs@thomsonreuters.com;))